EG plus DHC treatment increased formation of renal birefringent crystal. Histology revealed increased renal tubular pathology characterized by obstruction, distension, and interstitial inflammation. Crystalluria at all time points led to oxidative stress manifest as decreased cytosolic and mitochondrial glutathione, and increased activity of the antioxidant enzymes glutathione-reductase and -peroxidase (mitochondria), and glucose-6-phosphate dehydrogenase (cytosol). These changes were followed by a significant decrease in mitochondrial cytochrome c content at 2-3 weeks suggesting the involvement of apoptosis in the renal pathology. Mitochondrial oxygen consumption was severely impaired in the crystalluria group without increased mitochondrial superoxide formation. Some of these changes were also evident in hyperoxaluria at week 1, but were absent at later times and in all calciuric groups. Our data indicate that impaired electron flow did not cause superoxide formation however mitochondrial dysfunction contributes to pathological events when tubular crystal-cell interactions are uncontrolled, as in stones disease. 
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INTRODUCTION
Kidney stone formation is a complex process and involves a cascade of events, including crystal nucleation, growth and aggregation, retention within the renal tubules, and migration to the renal papillary surfaces (17) . Hyperoxaluria is a major risk factor of human idiopathic calcium oxalate disease and leads to increased calcium oxalate supersaturation and calcium oxalate stone formation (1) . Exposure to oxalate has been shown to be toxic to renal epithelial cells, which results in lipid peroxidation mediated by free radicals (42). Oxalate toxicity is mediated in part by activation of lipid signalling pathways that produce arachidonic acid, lysophospholipids, and ceramide (40) . These lipids in turn are able to disrupt mitochondrial function by increasing production of reactive oxygen intermediates (ROI), decreasing mitochondrial membrane potential, and increasing mitochondrial permeability (16) .
ROI generated by redox active and cell compartmentalised processes are involved in various diseases including cancer (8). ROI mediate damage via modification of lipids, proteins and DNA, and this can result in cell dysfunction which then leads to hyperplasia, necrosis or apoptosis. Mammalian cells rely on a spectrum of ROI scavenging enzymes, to prevent excessive oxidative stress. The balance between the pro-oxidant (generation of ROI) and the tissue antioxidant defences dictates the level of tissue injury. Central to this is the redox balance of glutathione, an Page 3 of 39 intracellular thiol that plays a key role in the detoxification of reactive oxygen intermediates (ROI) (28). Glutathione redox equilibrium is maintained by the enzymes glutathione peroxidase (GPx) and glutathione reductase (GR), whilst glucose-6-phosphate dehydrogenase (G6PDH) supplies reducing equivalents in the form of NADPH, a key cofactor in maintaining glutathione in its reduced form.
Oxalate exposure of renal cells results in pathological changes involving re-initiation of DNA synthesis, cell growth, cell injury and death (16; 21; 29; 39; 40) . Furthermore, we have shown that in an in vitro stone model using kidney epithelial cells, exposure to calcium oxalate (COM) resulted in an increased oxidative stress manifest as superoxide production (20) . In addition, we have identified that increased levels of superoxide in response to COM crystals, originating from the mitochondria, which consequently results in depletion of mitochondrial glutathione.
Whether it is free oxalate or COM that is responsible for cytotoxicity is a controversial issue. COM rather than free oxalate has been shown to be responsible for cell toxicity (11) and we have recently shown that mitochondrial superoxide formation although requiring free oxalate is potentiated by the presence and binding of crystals (26).
Further, mitochondrial dysfunction was recently shown to be a primary event in cultured renal epithelial cells exposed to COM (2) . However it has also been reported that free oxalate is cytotoxic to kidney cell lines (19) The aim of the current study was to examine whether this oxidative stress, which occurs as a result of the interaction between COM and tubular epithelial cells in culture also occurs in an animal model of crystalluria arising from hyperoxaluria and hypercalciuria. To achieve this we have used a rat COM crystalluria model comprising of low (0.5%) ethylene glycol feeding which raises urinary oxalate (22) , and 1, 25-dihydroxycholecalciferol the active metabolite of Vitamin D3, to raise Page 4 of 39 calcium levels in tubular fluid (13). To investigate whether the interaction of oxalate crystals with renal epithelial cells resulted in mitochondrial dysfunction leading to apoptotic events, some key mitochondrial parameters were investigated, specifically cytochrome c release from the mitochondrial inner membrane a necessary first step for initiation of apoptosis. Changes to biochemical parameters (antioxidant status, mitochondrial oxygen consumption, superoxide formation), resulting from COM crystal-tubular epithelial cell interactions, were also assessed. Laboratories (Burlingame, CA). pH was measured using a Radiometer PHN 84 meter fitted with a VWR Gelplas combination electrode.
METHODS
Materials
Animals and treatments:
All animals work was carried out according to UK Home Office approved guidelines, following UCL animal committee ethical approval. This rat model of calcium oxalate nephrolithiasis employed ethylene glycol (EG) to induce hyperoxaluria, and 1, 25-dihydroxycholecalciferol (DHC) dissolved in propylene glycol to initiate hypercalciuria and is a modification of that used by Halabe et al (12). Male Sprague-Dawley rats (250-280g) were maintained under constant conditions and were divided into 4 groups (control, EG, DHC and EG+DHC). Each group was then subdivided into 3 groups, each with 6 animals, with the above treatments for 1, 2 and 3 weeks.
Controls animals received water, whereas in the EG and EG+DHC experimental groups 0.5% EG was administered daily in drinking water. Fluid intake was monitored in all groups. DHC (50ng/100g of body weight) was administered intraperitoneally every other day to the EG+DHC (starting 24 hours after first exposure to EG) and the DHC groups. At various times throughout the treatment (3h to 21 days) urine was collected onto microscope slides pre-warmed to 37°C during animal handling and examined under light microscope immediately. After 7, 14 and 21 days of treatment animals were anaesthetised with halothane and urine was taken directly by needle from the bladder. The anaesthetised animals were sacrificed by cervical dislocation and the kidneys removed.
Tissue sampling
The right kidney was excised and immediately frozen in liquid nitrogen and stored at -80°C until use. The left kidney was washed in saline at 4°C, trimmed of adipose and connective tissue, weighed and homogenised in a Potter/Elvehjem homogeniser, (10% w/v) in buffer containing 0.25M sucrose, 5mM HEPES, 1mM EDTA and 0.1% bovine serum albumin pH 7.2 with protease inhibitor cocktail (AEBSF 1mM aprotinin 0.8µM, leupeptin 20µM bestatin 40µM pepstatin A 15µM and E-64 14µM). The whole homogenate was centrifuged at 1000g for 5min to remove the nuclear fraction and cell debris. The supernatant was then fractionated by centrifugation at 9.5 x10 cytosolic and membrane components. Mitochondria after 1 wash in original homogenisation media were resuspended (12-15 mg protein/ml) in the above buffer.
Contamination from the cytosol (lactate dehydrogenase measured spectrophotometrically at 340 nm by NADH oxidation), microsomes (glucose 6 phosphatase measured by the blue phosphomolybdous complex at 700 nm) and peroxisomes (urate oxidase measured by oxidation of urate at 292 nm) were all < 7.5%.
Western blot analysis
Mitochondria were isolated by differential centrifugation as described above.
Mitochondrial protein (30 µg) was suspended in Laemmli buffer, heated at 95°C for 5 min, and resolved by electrophoresis using 12.5% SDS-polyacrylamide gels and electrotransferred to nitrocellulose as described (24) . Blots were incubated with the anti-cytochrome c antibodies at 4 °C overnight in Tris buffered saline containing 0.1% Tween-20 and 0.5 % BSA, followed by horseradish peroxidase-conjugated anti-mouse secondary antibody for 1 h at room temperature. The signal was visualized by autoradiography using ECL Western Detection Reagent (Amersham Pharmacia Biotech UK, Little Chalfont, UK), followed by exposure to X-Omat AR film (Eastman Kodak Co.). Blots were incubated with anti-prohibitin antibodies, a mitochondrial marker, to determine equal loading of samples (34).
Calciuria and Crystalluria
The presence of urinary crystals was assessed by light microscopy on glass slides of freshly passed urine. Formation of stones was determined in cryosections examined by polarized light to determine the appearance and size of birefringent particles. Urine calcium was measured using an ion selective electrode.
Kidney histology
Analysis of renal histopathological changes and the location of the birefringent crystals were performed on 5 µm thick haematoxylin and eosin (H and E) stained sections using plain and polarised light by an experienced pathologist.
Superoxide: Lucigenin-dependent chemiluminescence assay
Superoxide (O 2 ·-) production was measured by chemiluminescence (CL), using lucigenin (10 µM), at sub-recycling concentration (20) . 
Total Glutathione measurements
Whole homogenates of fresh kidney were prepared as described above, and immediately processed for mitochondrial and cytoplasmic total glutathione (GSH + 
Antioxidant enzyme activities in the kidney fractions
The activity of antioxidant enzymes (glutathione peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase) was assayed spectrophotometrically (6).
Glutathione peroxidase (GPx) was determined by the oxidation of NADPH to NADP + during a reaction initiated by the addition of cumene-hydroperoxide linked to the reduction of oxidised glutathione with excess added glutathione reductase.
Glutathione reductase (GR) was determined by directly measuring the rate of NADPH oxidation in the presence of oxidised glutathione. Glucose-6-phosphate dehydrogenase (G-6PDH) activity was determined by measuring the rate of NADP+ reduction to NADPH in the presence of glucose-6-phosphate. In these assays the change in absorbance at 340 nm was continuously monitored in a Cary 1 spectrophotometer and activity expressed as units /g tissue. Measurements were run in double beam mode, samples being present in both beams and substrate omitted from the rear beam.
Mitochondrial Oxygen Consumption Rates
Oxygen consumption in freshly isolated mitochondria (1-1.5 mg protein/ml) in 1.5 ml of respiration buffer was assayed using a Clark electrode device (Rank Brothers, UK). Malate plus pyruvate at 5 and 2 mM (complex I) or succinate at 5 mM (complex II) were used to measure state IV respiration (ADP limited), and ADP (100 µM)
added to measure state III respiration (no substrate/cofactor limitation).
Urinary oxalate and calcium.
The oxalate concentration of urine was measured in supernatants prepared from samples centrifuged at 10000g for 1 minute by ion chromatography with suppressed conductivity detection on a IonPac AS4A anion chromatographic column using a Dionex high performance pump. Urinary calcium was measured in the same sample using an ion selective electrode. Oxalic acid and calcium chloride were used as standards.
Statistics
All values shown are means ± standard deviation (SD) from 4-6 animals unless otherwise stated. Student's t test was used to determine whether there was a significant difference between two groups (p< 0.05). When multiple means were compared, significance (p< 0.05) was determined by analysis of variance, followed by Fisher's protected least significant difference test.
RESULTS
Early urine crystal formation was checked by light microscopy. Freshly passed urine collected 24 hours after the start of EG feeding was clear of crystals and throughout the study urine remained either free of crystals or exhibited only slight crystal presence. Three hours after administration of DHC in EG fed animals crystal formation was observed (data not shown); whilst in animals treated only with DHC, crystal formation was either not detected or slight crystal nucleation was observed.
This situation was maintained throughout the 3 weeks of treatment.
The concentration of urinary free oxalate measured by conductivity after ion chromatography, Ionised calcium concentrations and urine pH are shown in Table 1 .
The crystalluria group (EG+DHC) had significantly lower oxalate levels than the EG alone group. This is a result of a proportion of the free oxalate being excreted as crystals which are removed from the urine before analysis. Kidney crystal and stones formation was analyzed by polarisation and light microscopy. The H & E stained cryosections were analyzed by polarisation microscopy (all data summarised in Table 2 ). Kidneys from the control group showed no signs of crystal formation and hence no birefringence during the 3 weeks treatment period. In contrast, polarisation microscopy revealed the presence of birefringent, small crystals in the distal tubules by 1 week EG+DHC treatment with iincreased size, brightness and birefringence of the crystals, at the 2 nd and 3rd weeks of treatment. In the kidneys from animals treated with either EG and DHC alone, no crystals were observes at week1, whilst at week 2 and 3 in some sections small crystals were observed but these were more isolated than the 1 week EG+DHC. and DHC 39±7 (ml/rat/day). These changes in the crystalluria group were accompanied by an observed distension of renal tubules and urolithiasis of the bladder resulting in urine retention.
Based on densitometry measurements, cytochrome c protein abundance in the mitochondria was significantly decreased by more than 25% in the EG+DH-treated group at week 2 and 3 when compared to control animals (p<0.05, Figure 2 ). In contrast, cytochrome c content during the first week of EG+DH-treatment was unchanged from that of control animals ( Figure 2) . Incubation with the secondary antibody or with control rabbit IgG resulted in no detectable staining of any 13 kDa band (data not shown), demonstrating complete specificity. Thus, kidney stone formation in this in vivo model was linked to a significant decrease in renal mitochondrial cytochrome c content.
Total glutathione from the kidney whole homogenate ( Figure 3A ) and the cytosolic fractions ( Figure 3B ) are shown. Throughout the three-week course of treatment in the EG+DHC group there was a significant decrease. There was also a significant decrease in whole homogenate and cytosolic glutathione at week 1 in the EG group;
however, no significant change in mitochondrial glutathione was observed and total glutathione was restored to control levels in subsequent weeks. The differences in whole cell and cytosolic glutathione between the EG and EG+DHC groups after 1 week treatment are not significant. Total mitochondrial glutathione levels, during the 3 weeks treatment, were monitored to investigate changes occurring in crystalluric kidney during stone formation ( Figure 3C ). There was a marked and significant decrease in total mitochondrial glutathione by week 1 in the EG+DHC group, which was exacerbated at weeks 2 and 3.
We further examined the enzymatic activities of GPx, GR as well as the redox supply (pentose phosphate pathway) enzyme G-6PDH. Both of the glutathione cycle enzymes were significantly increased in the mitochondrial fraction from the EG+DHC group after week 1 of treatment ( Figures 4A and B) . However, in subsequent weeks GPx and GR activities were restored to control levels, and the GPx change at 1 week appears to be not related to crystalluria as it is also present in the calciuria group. The activity of both these enzymes was unchanged in the cytosolic fraction (data not shown). G-6PDH was markedly increased in the EG+DHC group throughout the whole 3 weeks treatment ( Figure 4C ).
Mitochondrial oxygen consumption was measured to investigate if the electron transport chain was a potential source of the observed oxidative stress. Oxygen consumption, in kidney mitochondria of hyperoxaluria (EG treatment) or hypercalciuria groups; (DHC treatment), in the presence of malate and pyruvate (complex I substrates), was not significantly changed compared to the control.
However, the oxygen consumption in the crystalluria (EG+DHC group) was severely compromised. Representative traces of oxygen consumption during state IV (substrate only) and state III (added ADP) are shown ( Figure 5A ). The oxygen consumption rate during state III respiration was decreased by 60% at week 1 and by 80% after 2 and 3 weeks ( Figure 5B ). Using succinate, a complex II substrate, a smaller diminution (50%) of state III oxygen consumption rate was observed (data not shown). The observed differences in the EG+DHC group were significant (p<0.005) and more apparent during state III rather than state IV respiration, and more pronounced with complex I rather than complex II substrates.
Mitochondrial superoxide production measured as lucigenin chemiluminescence was markedly (>90%) decreased throughout the whole course of treatment in the EG+DHC group ( Figure 5C ). At week 1 both the hyperoxaluria and the hypercalciuria groups also showed a decreased lucigenin chemiluminescence, however this was much lower (<40%) than the crystalluria animals and was reversed by week 2 and 3 of treatment.
DISCUSSION
Previous studies have shown that 0.5% EG causes hyperoxaluria (22) and this was confirmed in our studies and that at the dose of DHC we employed there is a > 5 fold increase in urinary calcium (hypercalciuria) (7; 14). In addition, the serum calcium increase with DHC is independent of oral or intraperitoneal delivery routes. The appearance of calcium oxalate crystals in the kidney by the end of week 1 is similar to other reported studies of rat nephrolithiasis, where higher ethylene glycol treatments (0.75%) were used without simultaneous raising the urinary calcium (without vitamin D or DHC). Under these circumstances intra-renal crystal appearance was apparent within 1 week (15). In the current study, calcium oxalate crystals began to aggregate in the tubular lumen causing widening of the interstitial space. However, histological studies of kidneys from animals fed with only 0.5% ethylene glycol did not show any morphological differences. Our findings also differ from those of de Water et. al. (5) who showed using Vitamin D3 and 0.5% ethylene glycol that some of the rats showed calcium oxalate deposits in the renal cortex or medulla after 4 weeks. When 0.75% EG was used, the amount of kidney-associated crystals was proportionally higher. This disparity is most probably a result of differences in the potential of DHC, the active metabolite of VitD 3, to raise urinary calcium. In addition, Lee et al (22) have shown the presence of kidney stones in animals fed 0.5% EG alone, however this study was conducted over a longer single time period of 4 weeks. This demonstrates the ability to achieve crystalluria and kidney stones formation at lower doses of EG.
We demonstrate here using a specific glutathione assay that in mitochondria initiates caspase activation and apoptosis (37) . This also conforms to our observation of decreased cellular glutathione concentrations in crystalluric animals, indicative of oxidative stress. In particular decreased mitochondrial glutathione, which apart from its role in the regulation of mitochondrial function (27), is also associated with a decreased tolerance of these organelles to damaging insults (4), and has recently been shown to be critical to cell survival during hypoxia (23) .
Clearly, severe mitochondrial disruption in the form of diminished oxygen consumption is apparent in this model. In addition oxidant stress which results in an increased oxidized/reduced glutathione ratio and is accompanied by protein sulphydryl (P-SH) oxidation, promotes further cytochrome c linked events such as the opening of the permeability transition pore (32) and impairment of the mitochondrial-nuclear signaling pathway (10). Feeding with EG alone at the doses used in this study did not result in loss of cytochrome c -and hence by inference did not lead to apoptosis. Further studies will be needed to ascertain the location and induction of apoptosis markers in this animal model.
We had previously observed that mitochondrial derived superoxide was the source of oxidative stress in renal epithelial cells treated with COM in vitro (20) .
Mitochondrial oxygen consumption and superoxide formation were investigated in this model to determine whether the electron transport chain was compromised by the observed loss of cytochrome c and if mitochondria were also the source of oxidative stress in vivo. Oxygen consumption in kidney mitochondria of EG or DHC groups in the presence of malate and pyruvate, was not significantly changed compared to the control indicating that hyperoxaluria or hypercalciuria alone were ineffective in changing mitochondrial function which was in accordance with the cytochrome c data. By contrast, in nephrolithic kidney (EG+DHC) group, the rate at which oxygen was consumed was severely decreased. A restriction in electron flow, which was apparent mainly during state III respiration with complex I substrates, is normally associated with an increased incidence of electron leakage i.e. superoxide
formation. This is a consequence of the decreased flow of electrons and results from an increased concentration of ubisemiquinone of complex III during the Q cycle (30; 44). However, and in contrast to COM treatment in MDCK cells (20) this did not appear to be the case in this model as superoxide formation was decreased to a greater extent than oxygen consumption. This indicates that the redox state of ubiquinone, i.e. ratios of oxidised ubiquinone to ubisemiquinone to reduced ubiquinol (Q : Q -: QH) remained oxidised due to impaired mitochondrial reductive capacity (complex I and/or II). The minimal rate of superoxide production in contrast to the cell model may be explained by the loss of intra-membrane cytochrome c (absolute requirement for energy transduction) being of sufficient severity to restrict electron transfer and hence leakage. Contrary to this, at week one in the crystalluria group, when cytochrome c is unchanged from the control level, the electron flow has already significantly decreased. Similar changes in state III respiration have been observed in vitro in isolated rat kidney mitochondria (25). COM produced a dosedependent cyclosporine A independent decrease in State 3 respiration as well as a cyclosporine dependent increase in mitochondrial swelling. However, potassium oxalate did not mimic COM, suggesting that it is not the free oxalate ion that leads to cell damage. This is in contrast to other studies which have shown that free oxalate is potentially injurious to cells (18) .
There is also the possibility that with in vivo crystalluria, the changes to renal mitochondrial are of such severity that the accumulated loss of electron transfer intermediates compromise oxygen consumption and electron leakage. This accumulation is the result of synergy between diminished cofactor supply via substrate reductases (33), lowered cytochrome c levels, and upregulation of mitochondrial uncoupling protein-3 (3).
Other sources of ROI production could be responsible for the observed oxidative stress. These include NAD(P)H oxidase associated with the plasma-membrane and lipoxygenase (45). Although we found no evidence for these in COM treated MDCK cells (20) they cannot be discounted in this model.
We believe it is unlikely that physical obstruction of tubules is the cause of the 
